公开(公告)号：US20210395241A1

公开(公告)日：2021-12-23

申请号：US17252613

申请日：2019-07-02

Applicant: Novartis AG

Inventor： Gary GLICK ,  William R. Roush ,  Shankar VENKATRAMAN ,  Dong-Ming SHEN ,  Shomir GHOSH ,  Hans Martin SEIDEL ,  Luigi FRANCHI ,  David Guenther WINKLER ,  Anthony William OPIPARI ,  Jason KATZ

IPC: C07D417/12 ,  C07D277/36 ,  C07C311/51 ,  A61K45/06

Abstract: In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

公开(公告)号：US20230416211A1

公开(公告)日：2023-12-28

申请号：US18319630

申请日：2023-05-18

Applicant: NOVARTIS AG

Inventor： Luigi FRANCHI ,  Shomir GHOSH ,  Gary GLICK ,  Jason KATZ ,  Anthony William OPIPARI ,  William ROUSH ,  Hans Martin SEIDEL ,  Dong-Ming SHEN ,  Shankar VENKATRAMAN ,  David Guenther WINKLER

IPC: C07D277/36 ,  C07D307/64 ,  C07D333/34 ,  C07C307/06 ,  C07D215/36 ,  C07D231/18 ,  C07D239/26 ,  C07D263/46 ,  C07D307/79 ,  C07D317/62 ,  C07D487/04

CPC classification number: C07D277/36 ,  C07D307/64 ,  C07D333/34 ,  C07C307/06 ,  C07D215/36 ,  C07D231/18 ,  C07D239/26 ,  C07D263/46 ,  C07D307/79 ,  C07D317/62 ,  C07D487/04 ,  C07C335/42

Abstract: In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured:






or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.